NU SKIN ENTERPRISES INC - A (NUS) Fundamental Analysis & Valuation

NYSE:NUS • US67018T1051

Current stock price

7.46 USD
-0.01 (-0.13%)
At close:
7.46 USD
0 (0%)
Pre-Market:

This NUS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. NUS Profitability Analysis

1.1 Basic Checks

  • NUS had positive earnings in the past year.
  • NUS had a positive operating cash flow in the past year.
  • NUS had positive earnings in 4 of the past 5 years.
  • NUS had a positive operating cash flow in each of the past 5 years.
NUS Yearly Net Income VS EBIT VS OCF VS FCFNUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M

1.2 Ratios

  • The Return On Assets of NUS (11.40%) is better than 86.49% of its industry peers.
  • Looking at the Return On Equity, with a value of 19.90%, NUS belongs to the top of the industry, outperforming 86.49% of the companies in the same industry.
  • NUS has a better Return On Invested Capital (6.50%) than 62.16% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for NUS is significantly below the industry average of 10.52%.
  • The 3 year average ROIC (4.60%) for NUS is below the current ROIC(6.50%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.4%
ROE 19.9%
ROIC 6.5%
ROA(3y)0.63%
ROA(5y)3.08%
ROE(3y)-0.52%
ROE(5y)5.25%
ROIC(3y)4.6%
ROIC(5y)7.93%
NUS Yearly ROA, ROE, ROICNUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20

1.3 Margins

  • The Profit Margin of NUS (10.79%) is better than 83.78% of its industry peers.
  • In the last couple of years the Profit Margin of NUS has grown nicely.
  • NUS has a Operating Margin of 6.12%. This is in the better half of the industry: NUS outperforms 64.86% of its industry peers.
  • NUS's Operating Margin has declined in the last couple of years.
  • With a decent Gross Margin value of 69.45%, NUS is doing good in the industry, outperforming 64.86% of the companies in the same industry.
  • In the last couple of years the Gross Margin of NUS has remained more or less at the same level.
Industry RankSector Rank
OM 6.12%
PM (TTM) 10.79%
GM 69.45%
OM growth 3Y-5.09%
OM growth 5Y-9.32%
PM growth 3Y31.83%
PM growth 5Y7.79%
GM growth 3Y-1.04%
GM growth 5Y-1.4%
NUS Yearly Profit, Operating, Gross MarginsNUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. NUS Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NUS is destroying value.
  • The number of shares outstanding for NUS has been reduced compared to 1 year ago.
  • NUS has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for NUS has been reduced compared to a year ago.
NUS Yearly Shares OutstandingNUS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
NUS Yearly Total Debt VS Total AssetsNUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 3.73 indicates that NUS is not in any danger for bankruptcy at the moment.
  • NUS's Altman-Z score of 3.73 is amongst the best of the industry. NUS outperforms 81.08% of its industry peers.
  • The Debt to FCF ratio of NUS is 4.87, which is a neutral value as it means it would take NUS, 4.87 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 4.87, NUS is in the better half of the industry, outperforming 70.27% of the companies in the same industry.
  • NUS has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.25, NUS is in the better half of the industry, outperforming 62.16% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 4.87
Altman-Z 3.73
ROIC/WACC0.81
WACC8%
NUS Yearly LT Debt VS Equity VS FCFNUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.3 Liquidity

  • NUS has a Current Ratio of 2.08. This indicates that NUS is financially healthy and has no problem in meeting its short term obligations.
  • NUS has a Current ratio (2.08) which is comparable to the rest of the industry.
  • NUS has a Quick Ratio of 1.40. This is a normal value and indicates that NUS is financially healthy and should not expect problems in meeting its short term obligations.
  • NUS's Quick ratio of 1.40 is in line compared to the rest of the industry. NUS outperforms 56.76% of its industry peers.
Industry RankSector Rank
Current Ratio 2.08
Quick Ratio 1.4
NUS Yearly Current Assets VS Current LiabilitesNUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. NUS Growth Analysis

3.1 Past

  • NUS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.76%, which is quite impressive.
  • The earnings per share for NUS have been decreasing by -18.78% on average. This is quite bad
  • Looking at the last year, NUS shows a very negative growth in Revenue. The Revenue has decreased by -14.26% in the last year.
  • The Revenue for NUS have been decreasing by -10.47% on average. This is quite bad
EPS 1Y (TTM)51.76%
EPS 3Y-23.58%
EPS 5Y-18.78%
EPS Q2Q%-23.68%
Revenue 1Y (TTM)-14.26%
Revenue growth 3Y-12.62%
Revenue growth 5Y-10.47%
Sales Q2Q%-16.89%

3.2 Future

  • The Earnings Per Share is expected to grow by 1.27% on average over the next years.
  • Based on estimates for the next years, NUS will show a small growth in Revenue. The Revenue will grow by 1.05% on average per year.
EPS Next Y-21.71%
EPS Next 2Y1.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-4.69%
Revenue Next 2Y1.05%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NUS Yearly Revenue VS EstimatesNUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
NUS Yearly EPS VS EstimatesNUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

8

4. NUS Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 5.78 indicates a rather cheap valuation of NUS.
  • Compared to the rest of the industry, the Price/Earnings ratio of NUS indicates a rather cheap valuation: NUS is cheaper than 100.00% of the companies listed in the same industry.
  • NUS is valuated cheaply when we compare the Price/Earnings ratio to 27.47, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 7.39, the valuation of NUS can be described as very cheap.
  • 89.19% of the companies in the same industry are more expensive than NUS, based on the Price/Forward Earnings ratio.
  • NUS is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.62, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 5.78
Fwd PE 7.39
NUS Price Earnings VS Forward Price EarningsNUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NUS is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of NUS indicates a rather cheap valuation: NUS is cheaper than 89.19% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 7.97
EV/EBITDA 2.45
NUS Per share dataNUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The decent profitability rating of NUS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.27%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. NUS Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.14%, NUS has a reasonable but not impressive dividend return.
  • The stock price of NUS dropped by -32.55% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • Compared to an average industry Dividend Yield of 1.72, NUS pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.81, NUS pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.14%

5.2 History

  • The dividend of NUS decreases each year by -30.34%.
  • NUS has paid a dividend for at least 10 years, which is a reliable track record.
  • The dividend of NUS decreased recently.
Dividend Growth(5Y)-30.34%
Div Incr Years0
Div Non Decr Years1
NUS Yearly Dividends per shareNUS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 7.39% of the earnings are spent on dividend by NUS. This is a low number and sustainable payout ratio.
DP7.39%
EPS Next 2Y1.27%
EPS Next 3YN/A
NUS Yearly Income VS Free CF VS DividendNUS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M
NUS Dividend Payout.NUS Dividend Payout, showing the Payout Ratio.NUS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

NUS Fundamentals: All Metrics, Ratios and Statistics

NU SKIN ENTERPRISES INC - A

NYSE:NUS (4/23/2026, 8:04:00 PM)

Premarket: 7.46 0 (0%)

7.46

-0.01 (-0.13%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-12
Earnings (Next)05-07
Inst Owners78%
Inst Owner Change0.14%
Ins Owners3.92%
Ins Owner Change23.06%
Market Cap366.88M
Revenue(TTM)1.49B
Net Income(TTM)160.20M
Analysts45
Price TargetN/A
Short Float %4.79%
Short Ratio4.12
Dividend
Industry RankSector Rank
Dividend Yield 3.14%
Yearly Dividend0.24
Dividend Growth(5Y)-30.34%
DP7.39%
Div Incr Years0
Div Non Decr Years1
Ex-Date02-27
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.96%
Min EPS beat(2)-4.29%
Max EPS beat(2)12.21%
EPS beat(4)3
Avg EPS beat(4)38.88%
Min EPS beat(4)-4.29%
Max EPS beat(4)73.83%
EPS beat(8)6
Avg EPS beat(8)39.66%
EPS beat(12)9
Avg EPS beat(12)28.85%
EPS beat(16)12
Avg EPS beat(16)23.55%
Revenue beat(2)0
Avg Revenue beat(2)-3.91%
Min Revenue beat(2)-4.19%
Max Revenue beat(2)-3.63%
Revenue beat(4)2
Avg Revenue beat(4)-0.96%
Min Revenue beat(4)-4.19%
Max Revenue beat(4)2.51%
Revenue beat(8)4
Avg Revenue beat(8)-1.07%
Revenue beat(12)5
Avg Revenue beat(12)-1.25%
Revenue beat(16)6
Avg Revenue beat(16)-1.69%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-44.44%
EPS NY rev (1m)0%
EPS NY rev (3m)-29.58%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.59%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.67%
Valuation
Industry RankSector Rank
PE 5.78
Fwd PE 7.39
P/S 0.25
P/FCF 7.97
P/OCF 4.57
P/B 0.46
P/tB 0.54
EV/EBITDA 2.45
EPS(TTM)1.29
EY17.29%
EPS(NY)1.01
Fwd EY13.54%
FCF(TTM)0.94
FCFY12.54%
OCF(TTM)1.63
OCFY21.88%
SpS30.2
BVpS16.37
TBVpS13.81
PEG (NY)N/A
PEG (5Y)N/A
Graham Number21.7999 (192.22%)
Profitability
Industry RankSector Rank
ROA 11.4%
ROE 19.9%
ROCE 7.96%
ROIC 6.5%
ROICexc 8.23%
ROICexgc 9.57%
OM 6.12%
PM (TTM) 10.79%
GM 69.45%
FCFM 3.1%
ROA(3y)0.63%
ROA(5y)3.08%
ROE(3y)-0.52%
ROE(5y)5.25%
ROIC(3y)4.6%
ROIC(5y)7.93%
ROICexc(3y)5.71%
ROICexc(5y)10.2%
ROICexgc(3y)7.03%
ROICexgc(5y)13.41%
ROCE(3y)5.63%
ROCE(5y)9.71%
ROICexgc growth 3Y-12.47%
ROICexgc growth 5Y-21.24%
ROICexc growth 3Y-9.16%
ROICexc growth 5Y-17.8%
OM growth 3Y-5.09%
OM growth 5Y-9.32%
PM growth 3Y31.83%
PM growth 5Y7.79%
GM growth 3Y-1.04%
GM growth 5Y-1.4%
F-Score7
Asset Turnover1.06
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 4.87
Debt/EBITDA 1.43
Cap/Depr 65.59%
Cap/Sales 2.31%
Interest Coverage 5.44
Cash Conversion 56.09%
Profit Quality 28.72%
Current Ratio 2.08
Quick Ratio 1.4
Altman-Z 3.73
F-Score7
WACC8%
ROIC/WACC0.81
Cap/Depr(3y)69.21%
Cap/Depr(5y)75.81%
Cap/Sales(3y)2.56%
Cap/Sales(5y)2.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.76%
EPS 3Y-23.58%
EPS 5Y-18.78%
EPS Q2Q%-23.68%
EPS Next Y-21.71%
EPS Next 2Y1.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.26%
Revenue growth 3Y-12.62%
Revenue growth 5Y-10.47%
Sales Q2Q%-16.89%
Revenue Next Year-4.69%
Revenue Next 2Y1.05%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y78.98%
EBIT growth 3Y-17.06%
EBIT growth 5Y-18.81%
EBIT Next Year130.74%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-34.42%
FCF growth 3Y-2.08%
FCF growth 5Y-31.95%
OCF growth 1Y-28.15%
OCF growth 3Y-9.44%
OCF growth 5Y-26.69%

NU SKIN ENTERPRISES INC - A / NUS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for NU SKIN ENTERPRISES INC - A?

ChartMill assigns a fundamental rating of 6 / 10 to NUS.


What is the valuation status of NU SKIN ENTERPRISES INC - A (NUS) stock?

ChartMill assigns a valuation rating of 8 / 10 to NU SKIN ENTERPRISES INC - A (NUS). This can be considered as Undervalued.


What is the profitability of NUS stock?

NU SKIN ENTERPRISES INC - A (NUS) has a profitability rating of 7 / 10.


How financially healthy is NU SKIN ENTERPRISES INC - A?

The financial health rating of NU SKIN ENTERPRISES INC - A (NUS) is 7 / 10.


How sustainable is the dividend of NU SKIN ENTERPRISES INC - A (NUS) stock?

The dividend rating of NU SKIN ENTERPRISES INC - A (NUS) is 5 / 10 and the dividend payout ratio is 7.39%.